Tribute to Folke Sjöqvist, a Pioneer in Clinical Pharmacology

Qualitative study to explore which components of home-based primary care may reduce emergency department visits among older adults.

BMJ open·2026

Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.

Journal of the National Cancer Institute·2026

Understanding potentially avoidable emergency department visits in older adults: a survey with healthcare professionals across in- and outpatient care in Sweden.

BMJ open·2026

Correction: Li et al. Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers. J. Pers. Med. 2021, 11, 457.

Journal of personalized medicine·2026

Efavirenz metabolism and CNS toxicity in Ugandan children: impact of CYP2B6 genotype and plasma metabolite profiles.

Frontiers in pharmacology·2026

Optimizing cloxacillin prophylaxis in hip and knee arthroplasty based on population pharmacokinetics of unbound plasma concentrations.

The Journal of antimicrobial chemotherapy·2026

Model-Informed Dose Optimization of Anakinra in Preterm Neonates Implications for Safe and Effective Dosing.

Clinical pharmacology and therapeutics·2026

Untargeted Metabolomics Reveal New Endogenous Plasma Biomarkers Associated with CYP3A Inhibition in Humans.

Clinical pharmacology and therapeutics·2026

A Practical Guide to Implementing Real-World Evidence as Primary Basis for Approval and Label Expansion.

Clinical pharmacology and therapeutics·2026

Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications.

Clinical pharmacology and therapeutics·2026

Trust, but Verify: Translating Dosing Evidence to Understudied Populations in Low- and Middle-Income Countries.

Clinical pharmacology and therapeutics·2026

From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug Development.

Clinical pharmacology and therapeutics·2026

Efficacy and Safety of Erenumab in Preventive and Therapeutic Treatment of Patients Suffering from Migraine.

Annals of African medicine·2026

Monoacylglycerol Lipase Inhibition by JZL184 Improves Neurological Outcomes and Survival after Cardiac Arrest via 2-AG-Mediated Restoration of Cerebral Microcirculation.

Cannabis and cannabinoid research·2026

SARS-CoV-2 Drug-Resistant Mutations in Non-Structural Proteins.

Viruses·2026

Andrographolide as a Promising Diterpenoid Scaffold Against the Neurotropic Nematode Angiostrongylus cantonensis.

Pharmaceuticals (Basel, Switzerland)·2026

Quality by Design-Guided Development of Ketoprofen-Cationic Aspasomes Unlocks the Antifungal Potential of Repurposed Ketoprofen for Topical Therapy.

Pharmaceuticals (Basel, Switzerland)·2026

Exploring the Therapeutic Effects of Artemisia rupestris L. Extract on Metabolic Dysfunction-Associated Fatty Liver Disease: Network Pharmacology and In Vitro Experiments.

Pharmaceuticals (Basel, Switzerland)·2026

Related Experiment Videos

Tribute to Folke Sjöqvist, a Pioneer in Clinical Pharmacology

Related Concept Videos

Qualitative study to explore which components of home-based primary care may reduce emergency department visits among older adults.

Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.

Understanding potentially avoidable emergency department visits in older adults: a survey with healthcare professionals across in- and outpatient care in Sweden.

Correction: Li et al. Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers. J. Pers. Med. 2021, 11, 457.

Efavirenz metabolism and CNS toxicity in Ugandan children: impact of CYP2B6 genotype and plasma metabolite profiles.

Optimizing cloxacillin prophylaxis in hip and knee arthroplasty based on population pharmacokinetics of unbound plasma concentrations.

Model-Informed Dose Optimization of Anakinra in Preterm Neonates Implications for Safe and Effective Dosing.

Untargeted Metabolomics Reveal New Endogenous Plasma Biomarkers Associated with CYP3A Inhibition in Humans.

A Practical Guide to Implementing Real-World Evidence as Primary Basis for Approval and Label Expansion.

Model-based clinical pharmacology profiling of subcutaneous nivolumab in renal cell carcinoma: Bridging to alternative dosing regimens and indications.

Trust, but Verify: Translating Dosing Evidence to Understudied Populations in Low- and Middle-Income Countries.

From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug Development.

Efficacy and Safety of Erenumab in Preventive and Therapeutic Treatment of Patients Suffering from Migraine.

Monoacylglycerol Lipase Inhibition by JZL184 Improves Neurological Outcomes and Survival after Cardiac Arrest via 2-AG-Mediated Restoration of Cerebral Microcirculation.

SARS-CoV-2 Drug-Resistant Mutations in Non-Structural Proteins.

Andrographolide as a Promising Diterpenoid Scaffold Against the Neurotropic Nematode Angiostrongylus cantonensis.

Quality by Design-Guided Development of Ketoprofen-Cationic Aspasomes Unlocks the Antifungal Potential of Repurposed Ketoprofen for Topical Therapy.

Exploring the Therapeutic Effects of Artemisia rupestris L. Extract on Metabolic Dysfunction-Associated Fatty Liver Disease: Network Pharmacology and In Vitro Experiments.

Related Experiment Videos

Tribute to Folke Sjöqvist, a Pioneer in Clinical Pharmacology

Related Concept Videos

Related Articles